---
document_datetime: 2025-06-19 12:34:40
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/zelboraf-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: zelboraf-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.4686605
conversion_datetime: 2025-12-28 15:02:20.928074
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Zelboraf

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproductlifecycleprocedures,youmayneed to alsorefer toEPAR-Procedural steps taken and scientific information after authorisation (archive).

| Applicationnumber   | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Article 61(3) /     | -Notification acc. Article 61(3) - | 19/06/2025                          |                                          | PL                              |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/N/0000279644                    | Update the package leaflet to delete the list ofcontactdetailsoflocalrepresentatives and delete 'United Kingdom (Northern Ireland)' from the list of local representatives inlinewith theQRD template v10.4.Additionally, the MAH is taking the opportunity to add the \"E\" numbersfortheexcipientsinSection6of the PL in alignment with the SmPC and update CS,IT,DA,and PL languages accordingtotheQRDwording                                                                                |            |     |
|-------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation typeIA/ EMA/VR/0000263877 | A. ADMINISTRATIVE CHANGES -A.4 Change in thename and/or addressof:a manufacturer(includingwhererelevant quality control testing sites);or anASMF holder; or a supplier of the active substance, startingmaterial,reagentorintermediate usedinthemanufactureoftheactive substance(where specified in the technical dossier)where noPh.Eur.Certificate of Suitabilityispart of the approved dossier;or a manufacturer of a novel excipient (where specified in the technical dossier)- Accepted | 03/04/2025 | N/A |